CS

Chikkapura Shanthaveerappa Nagaraja

Director Director DIN 03474293
DIN 03474293 First appointment Apr 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Chikkapura Shanthaveerappa Nagaraja

Data last updated:

Chikkapura Shanthaveerappa Nagaraja was a Director at Teru Technomed Private Limited (2011–2012) and Director at Canris Pharma India Private Limited (from 2012). The companies operate in Healthcare.

DIN 03474293
Primary Designation Director
Industry Healthcare
First Appointment 07 Apr 2011
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Teru Technomed Private Limited U33100KA2011PTC058040
Director07 Apr 20112011₹8.9 Lakh (FY 2016)Strike Off
Canris Pharma India Private Limited U85100KA2012PTC063264
Director28 Mar 20122012₹7,573 (FY 2020)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Canris Pharma India Private Limited
Teru Technomed Private Limited
Premium access

Shareholding and investment profile for Chikkapura Shanthaveerappa Nagaraja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chikkapura Shanthaveerappa Nagaraja

Chikkapura Shanthaveerappa Nagaraja was first appointed on 07 Apr 2011 as Director at Teru Technomed Private Limited. The most recent appointment on record is 28 Mar 2012 at Canris Pharma India Private Limited.

Chikkapura Shanthaveerappa Nagaraja held 2 earlier board appointments: Teru Technomed Private Limited (Director, 07 Apr 2011 to 10 Dec 2012); Canris Pharma India Private Limited (Director, from 28 Mar 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available